LiveActive security incident?Get immediate response
CVE Record

CVE-2019-2629: Vulnerability in the Oracle Health Sciences Data Management Workbench component of Oracle Health Sciences A...

Vulnerability in the Oracle Health Sciences Data Management Workbench component of Oracle Health Sciences Applications (subcomponent: User Interface). The supported version that is affected is 2.4.8. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Health Sciences Data Management Workbench. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Health Sciences Data Management Workbench accessible data as well as unauthorized read access to a subset of Oracle Health Sciences Data Management Workbench accessible data. CVSS 3.0 Base Score 5.4 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N).

UnknownCVSS not scoredNot KEV-listedUpdated
Discuss exposureBack to CVEs
Glexia's TakeAutomated analysis

Security readout for executives and security teams

CVE-2019-2629 affects Oracle Health Sciences Data Management Workbench 2.4.8. A low-privileged user with HTTP network access could read some data and make unauthorized changes to some accessible data. The main business concern is integrity and confidentiality of regulated health-sciences data, not service outage. Exposure is likely limited to organizations running Oracle Health Sciences Data Management Workbench version 2.4.8 where HTTP access is available to low-privileged users. The source bundle does not identify other affected versions or products. Treat as a moderate-priority remediation item, elevated where DMW handles sensitive clinical or regulated data. The vulnerability can affect data integrity and confidentiality, but the sources do not indicate unauthenticated access, availability impact, or confirmed exploitation. Mitigation focus: Check Oracle's April 2019 Critical Patch Update guidance for the affected product.; Prioritize remediation for internet-facing or broadly reachable DMW deployments.; Restrict HTTP access to trusted networks and required user groups..

Prepared

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2019-2629 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
1Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Oracle CorporationHealth Sciences Data Management Workbench2.4.8Listed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.